Extradural analgesia using bupivacaine or opioids, alone or in combination, has become a well established and effective means of controlling postoperative pain. To date, much of the work investigating the combination of bupivacaine and opioids relates to patients in labour. These studies demonstrate that the addition of lipid-soluble opioids to bupivacaine results in improved analgesia [1] and can reduce bupivacaine-related side effects [2] . Whilst the use of the combination of bupivacaine and the lipid-soluble opioid fentanyl is gaining in popularity after surgery, it has been investigated less thoroughly than in obstetric practice. Indeed, recent work has produced conflicting results [3] [4] [5] .
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The aim of this study was to use patient-controlled extradural analgesia (PCEA) to compare extradural bupivacaine, fentanyl and the combination of both, for postoperative pain relief. The concentrations of bupivacaine and fentanyl chosen were those used routinely in combination in our centre for postoperative pain relief by extradural infusion. The use of patient-controlled analgesia (PCA) allows patients to titrate analgesics to their own individual requirements and it has been recommended for use in comparative analgesic studies [6] .
PATIENTS AND METHODS
After obtaining Hospital Ethics Committee approval and informed consent, we studied ASA I-III patients undergoing knee or hip replacement surgery, and having an extradural inserted as part of their anaesthetic technique.
Patients were educated in the use of PCEA and the 100-mm visual analogue score before operation. All patients were given a combined extradural and general anaesthetic. Premedication, if required, comprised oral temazepam 1-2 h before operation. A Portex extradural catheter was inserted in a lumbar space before, or shortly after, induction of anaesthesia and an extradural block was established with 0.5 % bupivacaine 10-15 ml. The L2-3 or L3-4 space was chosen preferentially, otherwise Ll-2 or L4-5 was used according to ease of catheter insertion. After an i.v. induction, anaesthesia was maintained with nitrous oxide and a volatile agent in oxygen. Additional intraoperative analgesia, if required, was provided by fentanyl up to 200 ug i.v. At the completion of surgery, the extradural catheter was connected to a Graseby PCA machine which was loaded with a preformulated, randomized syringe of extradural trial solution. This contained 0.125% bupivacaine (bupivacaine group), fentanyl 5 ngml" 1 (fentanyl group), or 0.125% bupivacaine combined with fentanyl 5 ug ml" 1 (combined group). The PCA settings allowed for a bolus of 4 ml to be given over 5 min with a lock-out time of 10 min. All patients, anaesthetists and nursing staff were blinded to the patient groupings: the syringes were prepared by one of the authors not involved with patient management.
The study lasted for 24 h from the end of the operation, during which time the patients were managed in a High Dependency Unit. Patients were free to use PCEA from the end of the operation. If analgesia was inadequate, as judged by the patient, nursing or medical staff, a maximum of two 10-ml boluses of trial solution, at least 20 min apart, could be given. If analgesia remained inadequate, the study stopped at that point and the correct catheter position was tested with 10 ml of 1 % lignocaine. Data were included if motor and sensory block were elicited.
The pain; 100 mm = worst pain imaginable) at 2, 6, 12 and 24 h after operation. Assessments of nausea, motor block, pruritus and sedation were recorded at the same times on 3-, 5-, 4-and 4-point scales, respectively. Arterial pressure and ventilatory frequency were recorded hourly and more frequently if there was hypotension (systolic AP < 100 mm Hg) or respiratory depression (ventilatory frequency < lOb.p.m.).
Results were compared using Kruskal-Wallis and Mann-Whitney tests with P < 0.05 taken as significant.
RESULTS
We studied 60 patients (tables I and II). The three groups were matched evenly in gender, age, weight and type of operation. Relatively more extradurals were sited at L3-4 than L2-3 in the bupivacaine group compared with the fentanyl and combined groups. Patients having knee or hip replacement surgery were matched evenly within age, weight and type of extradural solution. The ratio of females to males was greater and there were relatively more extradurals sited at L3-^ for knee replacement than for hip replacement patients. A tourniquet was used for all knee replacement surgery.
The mean (SD) total volume of extradural solution administered over the 24-h study period was significantly smaller in the combined group (89 (42) ml), compared with the bupivacaine group (113 (46) ml) and the fentanyl group (117 (46) ml) (P < 0.05 and P < 0.01, respectively) ( fig. 1, table III) . Supplementary bolus doses were given to four patients in the bupivacaine group (mean volume 14 ml), three in the fentanyl group (mean volume 17 ml) and three in the combined group (mean volume 15 ml). The mean total volume of extradural solution administered was significantly greater for patients having knee replacement (126 (46) ml) than for those having hip replacement (84 (35) ml) (P < 0.001). Supplementary bolus doses were given to seven knee replacement patients (mean volume 16 ml) and three hip replacement patients (mean volume 13 ml).
The mean pain scores over the 24-h study period for the fentanyl group (12 (7) mm) and the combined group (11 (10) mm) were smaller than for the bupivacaine group (17 (12) mm), although this was not significant ( fig. 2, table III) . The mean pain score was significantly greater for knee replacement patients (16 (10 mm) than for those having hip replacement (10 (9) mm) (P < 0.05). Patient gender or positioning of the extradural catheter at L2-3 or L3-4 did not make a significant difference to the volume of solution administered, or pain scores, over the 24-h study period. Nausea, motor block, pruritus and sedation were not significantly different between the three groups. However, the combined group had less nausea and motor block compared with the two other groups, while the bupivacaine group had less pruritus compared with the fentanyl and combined groups (table IV) .
Hypotension (defined as a systolic AP < 100 mm Hg) occurred in four of 19 patients in the bupivacaine group, compared with four of 20 in the fentanyl group and eight of 21 in the combined group after surgery, but before commencement of PCEA. This compared with eight of 19 in the bupivacaine group, two of 20 in the fentanyl group and 10 of 21 in the combined group after commencement of PCEA.
A ventilatory frequency less than 10 b.p.m. was not recorded for any patient after commencement of PCEA. There was no difference in the mean minimum ventilatory frequency between the bupivacaine group (12.8 (1.6) b.p.m.) , the fentanyl group (12.5 (2.0) b.p.m.) and the combined group (12.7 (2.1) b.p.m.).
Two patients receiving bupivacaine did not complete the full 24-h study period. One had inadequate analgesia (despite good catheter position) and another found the "numbness" disconcerting and requested withdrawal. A third patient receiving fentanyl requested withdrawal within 2 h because of pruritus. The extradural catheter level was not recorded for this patient.
DISCUSSION
Our results demonstrated that combining extradural bupivacaine and fentanyl decreased requirements of each individual agent. Addition of bupivacaine to fentanyl led to a 24 % reduction in fentanyl administration by PCEA, whilst adding fentanyl to bupivacaine led to a 21 % reduction in bupivacaine administration by PCEA. This implied that bupivacaine and fentanyl were at least additive in their analgesic actions, and that the contribution of each agent to the combination of both was of a similar magnitude.
These findings differ from those of a similar study [5] using continuous lumbar extradural infusions which found that low-dose bupivacaine did not improve postoperative extradural fentanyl analgesia in orthopaedic patients. That study compared fentanyl 10 jig ml" 1 alone and 0.1 % bupivacaine combined with fentanyl 10 ug ml" 1 , given by extradural infusion after knee replacement. The mean doses of bupivacaine and fentanyl administered in the combined group were of the order of 8 mg h" 1 and 80 ug h" 1 , respectively (ratio of bupivacaine: fentanyl = lmg:10ug). This compared with mean doses of bupivacaine 5.8 mg hr 1 and fentanyl 23 ugh" 1 for the knee replacement patients in our combined group (ratio of bupivacaine: fentanyl = 1 mg:4 ug). We suggest that the relatively large dose of fentanyl used in that study may have masked any beneficial effect of the addition of bupivacaine to fentanyl.
More recent work [3] , comparing continuous thoracic extradural infusions of 0.2% bupivacaine, fentanyl 10 ug ml" 1 and a combination of both, after abdominal aortic surgery, is in greater concordance with our results. In that study, the combined group had superior analgesia compared with each agent used alone. A mean dose of bupivacaine 9.3 mg h" 1 and fentanyl 46 ug h" 1 was administered. Whilst the concentrations and doses of bupivacaine and fentanyl used were greater, the dose ratio of the two (1 mg:5 ug) was similar to that used in our study (1 mg:4 ug). The optimum dose ratio for extradural bupivacaine and fentanyl is likely to be closer to these values than that used in the orthopaedic study of Badner and colleagues [5] .
The side effects encountered in our study were of a minor nature. There was no significant difference between the groups for nausea, motor block, pruritus or sedation. Respiratory depression (ventilatory frequency < 10 b.p.m.) was not encountered in any group. A systolic AP of < 100 mm Hg was recorded in 20 of 60 patients after commencement of PCEA. In the study comparing similar groups after aortic surgery [3] , no patient had a systolic AP of less than 100 mm Hg. It is possible that the administration of small boluses of bupivacaine (5 mg) by PCEA in our study, as opposed to a continuous infusion, contributed to this difference. A more likely explanation is that the invasive monitoring used in the aortic patients enabled more rapid detection and treatment of hypovolaemia, thus preventing hypotension. The problem of postoperative hypotension should be balanced against the reduction in extradural fentanyl requirements and possible reduction in deep vein thrombosis [7] produced by extradural bupivacaine.
A coincidental finding in our study was that, after knee replacement, 50% more extradural solution was used than after hip replacement. Despite this, the average pain score was significantly greater than after hip replacement. We conclude that knee replacement was more painful than hip replacement.
The technique of PCEA was accepted well by this rather elderly group of patients. It allowed patients to administer analgesia more closely to their widely varying individual needs. However, all groups did not quite achieve uniformly low pain scores, in particular the bupivacaine group at 24 h after operation had a greater mean pain score than the two other groups ( fig. 2 ). This may have resulted from regression and tachyphylaxis [8, 9] but, if so, we cannot explain why the patients did not increase the bupivacaine administration to counter this.
There may be advantages in using PCEA routinely. The average hourly amount of bupivacaine or fentanyl used after knee replacement by patients with PCEA in our study was of the order of 33 % of that reported for patients with continuous extradural infusions after knee replacement [5, 10] . This is in agreement with a study comparing administration of fentanyl by either PCEA or continuous extradural infusion following abdominal surgery [11] . It was suggested that psychological or pharmacological mechanisms may be responsible for this difference. Reduction in anxiety may have increased the placebo effect of PCEA. Intermittent bolus administration of drugs may have allowed greater CSF penetration of fentanyl than a continuous infusion. In addition, spread of extradural solution after bolus administration may be greater than with infusion. This is more likely to be a factor for fentanyl than for bupivacaine. In order to block knee or hip pain, the spinal analgesic action of fentanyl would occur in the lower thoracic region, as opposed to the lumbar region for bupivacaine. Whatever the mechanism, the potential for PCEA to reduce analgesic dosage, whilst at the same time maintaining analgesic efficacy, warrants further investigation.
